Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Infusion Devices Market, by Product Type, by Technology, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 ...

According to a recent study by Future Market Insights (FMI), the global intraosseous (IO) infusion devices is expected to witness high growth during the forecast period. The market is expected to grow ...

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 3, 2016) - Pyng Medical Corp. (TSX VENTURE:PYT), an award-winning developer of trauma and resuscitation products for emergency, combat and critical care ...

NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that its ...

Future Market Insights delivers key insights on the global Intraosseous Infusion Devices market in a new publication titled “Intraosseous Infusion Devices Market: Global Industry Analysis & ...

NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced that physicians at the Clinica ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Intraosseous vancomycin infusion during total hip arthroplasty was feasible for timely delivery of ...

Pavmed Inc. implanted its Portio system in three patients in a first-in-human (FIH) study of its intraosseous infusion system and successfully infused fluids in all patients without complications. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Intraosseous delivery of vancomycin after tourniquet ...

First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...